nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—CYP3A4—bone cancer	0.526	1	CbGaD
Nateglinide—SLC16A1—Methotrexate—bone cancer	0.187	0.462	CbGbCtD
Nateglinide—ABCC4—Methotrexate—bone cancer	0.0898	0.222	CbGbCtD
Nateglinide—SLC22A6—Methotrexate—bone cancer	0.0391	0.0967	CbGbCtD
Nateglinide—ALB—Methotrexate—bone cancer	0.0333	0.0823	CbGbCtD
Nateglinide—CYP2C9—Cisplatin—bone cancer	0.0276	0.0683	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—bone cancer	0.0169	0.0419	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—bone cancer	0.0108	0.0266	CbGbCtD
Nateglinide—PPARG—periosteum—bone cancer	0.00144	0.152	CbGeAlD
Nateglinide—ORM1—vertebral column—bone cancer	0.00127	0.135	CbGeAlD
Nateglinide—PPARG—leg—bone cancer	0.00115	0.121	CbGeAlD
Nateglinide—PPARG—forelimb—bone cancer	0.00114	0.12	CbGeAlD
Nateglinide—PPARG—hindlimb—bone cancer	0.00102	0.108	CbGeAlD
Nateglinide—PPARG—appendage—bone cancer	0.000878	0.0928	CbGeAlD
Nateglinide—PPARG—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000586	0.00983	CbGpPWpGaD
Nateglinide—KCNJ11—Regulation of insulin secretion—GNA11—bone cancer	0.000579	0.0097	CbGpPWpGaD
Nateglinide—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000574	0.00962	CbGpPWpGaD
Nateglinide—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000573	0.0096	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—bone cancer	0.000548	0.00918	CbGpPWpGaD
Nateglinide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00054	0.00905	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000531	0.0089	CbGpPWpGaD
Nateglinide—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000506	0.00849	CbGpPWpGaD
Nateglinide—UGT1A9—PPAR Alpha Pathway—CDK4—bone cancer	0.000492	0.00826	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—ZNF77—bone cancer	0.000471	0.0079	CbGpPWpGaD
Nateglinide—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	0.000471	0.00789	CbGpPWpGaD
Nateglinide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00047	0.00788	CbGpPWpGaD
Nateglinide—ABCC8—Integration of energy metabolism—GNA11—bone cancer	0.000469	0.00787	CbGpPWpGaD
Nateglinide—KCNJ11—Integration of energy metabolism—GNA11—bone cancer	0.000455	0.00763	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—SPARC—bone cancer	0.000451	0.00756	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000429	0.0072	CbGpPWpGaD
Nateglinide—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000423	0.0071	CbGpPWpGaD
Nateglinide—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.00042	0.00704	CbGpPWpGaD
Nateglinide—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000409	0.00686	CbGpPWpGaD
Nateglinide—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000407	0.00683	CbGpPWpGaD
Nateglinide—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000404	0.00677	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000378	0.00633	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000374	0.00628	CbGpPWpGaD
Nateglinide—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000369	0.00618	CbGpPWpGaD
Nateglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000348	0.00584	CbGpPWpGaD
Nateglinide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000342	0.00574	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.000339	0.00569	CbGpPWpGaD
Nateglinide—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000338	0.00566	CbGpPWpGaD
Nateglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00031	0.0052	CbGpPWpGaD
Nateglinide—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.000306	0.00513	CbGpPWpGaD
Nateglinide—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000288	0.00483	CbGpPWpGaD
Nateglinide—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000277	0.00465	CbGpPWpGaD
Nateglinide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000275	0.0046	CbGpPWpGaD
Nateglinide—Bortezomib—CYP3A4—bone cancer	0.000274	0.571	CrCbGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—CDK4—bone cancer	0.000272	0.00456	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—MET—bone cancer	0.000272	0.00456	CbGpPWpGaD
Nateglinide—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000269	0.00451	CbGpPWpGaD
Nateglinide—UGT1A9—Phase II conjugation—GSTP1—bone cancer	0.000256	0.00429	CbGpPWpGaD
Nateglinide—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000256	0.00429	CbGpPWpGaD
Nateglinide—PPARG—connective tissue—bone cancer	0.000251	0.0265	CbGeAlD
Nateglinide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000247	0.00415	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000247	0.00414	CbGpPWpGaD
Nateglinide—KCNJ11—tendon—bone cancer	0.000245	0.0259	CbGeAlD
Nateglinide—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000244	0.00409	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—bone cancer	0.000243	0.00407	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—CDK4—bone cancer	0.00024	0.00403	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—RB1—bone cancer	0.000236	0.00396	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—DHFR—bone cancer	0.000233	0.00391	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—ZNF77—bone cancer	0.000227	0.0038	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000219	0.00367	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000218	0.00366	CbGpPWpGaD
Nateglinide—ABCC8—spinal cord—bone cancer	0.000218	0.023	CbGeAlD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000208	0.00349	CbGpPWpGaD
Nateglinide—Enalapril—CYP3A4—bone cancer	0.000206	0.429	CrCbGaD
Nateglinide—SLC16A1—tendon—bone cancer	0.000205	0.0217	CbGeAlD
Nateglinide—ALB—Platelet degranulation—SPARC—bone cancer	0.000204	0.00342	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—MDM2—bone cancer	0.000202	0.00338	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000201	0.00337	CbGpPWpGaD
Nateglinide—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.0002	0.00336	CbGpPWpGaD
Nateglinide—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	0.0002	0.00336	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.0002	0.00335	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—GNA11—bone cancer	0.000198	0.00333	CbGpPWpGaD
Nateglinide—SLC16A1—spinal cord—bone cancer	0.000198	0.0209	CbGeAlD
Nateglinide—ABCC4—NRF2 pathway—GSTP1—bone cancer	0.000198	0.00331	CbGpPWpGaD
Nateglinide—ABCC4—NRF2 pathway—TGFBR2—bone cancer	0.000198	0.00331	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—EZH2—bone cancer	0.000198	0.00331	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000196	0.00329	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000194	0.00326	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000188	0.00316	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000183	0.00307	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000182	0.00306	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00018	0.00302	CbGpPWpGaD
Nateglinide—ORM1—bone marrow—bone cancer	0.000178	0.0189	CbGeAlD
Nateglinide—ORM1—spinal cord—bone cancer	0.000178	0.0188	CbGeAlD
Nateglinide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000176	0.00295	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—JUN—bone cancer	0.000175	0.00294	CbGpPWpGaD
Nateglinide—UGT1A9—Biological oxidations—CYP3A4—bone cancer	0.000175	0.00294	CbGpPWpGaD
Nateglinide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000174	0.00292	CbGpPWpGaD
Nateglinide—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000174	0.00291	CbGpPWpGaD
Nateglinide—UGT1A9—Metapathway biotransformation—CYP3A4—bone cancer	0.000173	0.0029	CbGpPWpGaD
Nateglinide—PPARG—tendon—bone cancer	0.000172	0.0182	CbGeAlD
Nateglinide—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000172	0.00288	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—GSTP1—bone cancer	0.000171	0.00286	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—TGFBR2—bone cancer	0.000171	0.00286	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—NDUFA12—bone cancer	0.00017	0.00286	CbGpPWpGaD
Nateglinide—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.00017	0.00285	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000169	0.00284	CbGpPWpGaD
Nateglinide—PPARG—bone marrow—bone cancer	0.000167	0.0176	CbGeAlD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000166	0.00278	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—NDUFA12—bone cancer	0.000165	0.00277	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—NDUFA12—bone cancer	0.000163	0.00273	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—NR1I2—bone cancer	0.000159	0.00267	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000158	0.00265	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000157	0.00264	CbGpPWpGaD
Nateglinide—ABCC4—tendon—bone cancer	0.000156	0.0165	CbGeAlD
Nateglinide—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000155	0.00261	CbGpPWpGaD
Nateglinide—ABCC4—bone marrow—bone cancer	0.000151	0.016	CbGeAlD
Nateglinide—UGT1A9—Biological oxidations—GSTP1—bone cancer	0.00015	0.00251	CbGpPWpGaD
Nateglinide—UGT1A9—Metapathway biotransformation—GSTP1—bone cancer	0.000148	0.00248	CbGpPWpGaD
Nateglinide—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000147	0.00247	CbGpPWpGaD
Nateglinide—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000145	0.00244	CbGpPWpGaD
Nateglinide—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000143	0.00239	CbGpPWpGaD
Nateglinide—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000143	0.00239	CbGpPWpGaD
Nateglinide—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000141	0.00237	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—NT5C3A—bone cancer	0.000141	0.00237	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—SPARC—bone cancer	0.000138	0.00232	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—RB1—bone cancer	0.000137	0.00231	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—NT5C3A—bone cancer	0.000137	0.0023	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000135	0.00227	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—NT5C3A—bone cancer	0.000135	0.00226	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000134	0.00225	CbGpPWpGaD
Nateglinide—PTGS1—connective tissue—bone cancer	0.000134	0.0142	CbGeAlD
Nateglinide—SLC15A2—spinal cord—bone cancer	0.00013	0.0137	CbGeAlD
Nateglinide—SLC16A1—Hemostasis—GNA11—bone cancer	0.000126	0.00212	CbGpPWpGaD
Nateglinide—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000126	0.00211	CbGpPWpGaD
Nateglinide—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000124	0.00208	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NDUFA12—bone cancer	0.000122	0.00205	CbGpPWpGaD
Nateglinide—PTGS1—Biological oxidations—GSTP1—bone cancer	0.000122	0.00205	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000117	0.00196	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IL3—bone cancer	0.000115	0.00192	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—CDK4—bone cancer	0.000112	0.00187	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—FUS—bone cancer	0.000111	0.00186	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000108	0.00181	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000106	0.00179	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—BRAF—bone cancer	0.000106	0.00178	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000105	0.00176	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NDUFA12—bone cancer	0.000105	0.00176	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SPARC—bone cancer	0.000103	0.00173	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—BRAF—bone cancer	0.000103	0.00172	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NT5C3A—bone cancer	0.000101	0.0017	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—GNA11—bone cancer	9.43e-05	0.00158	CbGpPWpGaD
Nateglinide—PTGS1—tendon—bone cancer	9.21e-05	0.00973	CbGeAlD
Nateglinide—CYP3A5—Biological oxidations—GSTP1—bone cancer	9.11e-05	0.00153	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	9.05e-05	0.00152	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	8.98e-05	0.00151	CbGpPWpGaD
Nateglinide—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	8.94e-05	0.0015	CbGpPWpGaD
Nateglinide—PTGS1—spinal cord—bone cancer	8.88e-05	0.00938	CbGeAlD
Nateglinide—ABCC8—Neuronal System—MDM2—bone cancer	8.88e-05	0.00149	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NDUFA12—bone cancer	8.83e-05	0.00148	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NT5C3A—bone cancer	8.7e-05	0.00146	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—MDM2—bone cancer	8.61e-05	0.00144	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NDUFA12—bone cancer	8.56e-05	0.00144	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IL3—bone cancer	8.55e-05	0.00143	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	8.28e-05	0.00139	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NR1I2—bone cancer	7.67e-05	0.00129	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.57e-05	0.00127	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—PLAU—bone cancer	7.52e-05	0.00126	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—CYP3A4—bone cancer	7.51e-05	0.00126	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	7.5e-05	0.00126	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.47e-05	0.00125	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	7.4e-05	0.00124	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NT5C3A—bone cancer	7.32e-05	0.00123	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—JUN—bone cancer	7.19e-05	0.00121	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NT5C3A—bone cancer	7.09e-05	0.00119	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.03e-05	0.00118	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	6.94e-05	0.00116	CbGpPWpGaD
Nateglinide—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.53e-05	0.0011	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.48e-05	0.00109	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—GSTP1—bone cancer	6.42e-05	0.00108	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.39e-05	0.00107	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NDUFA12—bone cancer	6.38e-05	0.00107	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	6.33e-05	0.00106	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ENO2—bone cancer	6.19e-05	0.00104	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.07e-05	0.00102	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ENO2—bone cancer	6e-05	0.00101	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ENO2—bone cancer	5.91e-05	0.000992	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—DHFR—bone cancer	5.74e-05	0.000963	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—EIF2S1—bone cancer	5.67e-05	0.00095	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PLAU—bone cancer	5.61e-05	0.00094	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—DHFR—bone cancer	5.57e-05	0.000933	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NDUFA12—bone cancer	5.5e-05	0.000922	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—DHFR—bone cancer	5.49e-05	0.00092	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MET—bone cancer	5.43e-05	0.000911	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—CDK4—bone cancer	5.43e-05	0.000911	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GNA11—bone cancer	5.36e-05	0.0009	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NT5C3A—bone cancer	5.29e-05	0.000887	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—bone cancer	5.2e-05	0.000873	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GNA11—bone cancer	5.2e-05	0.000872	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GNA11—bone cancer	5.13e-05	0.00086	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—EZH2—bone cancer	4.92e-05	0.000825	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP3A4—bone cancer	4.86e-05	0.000816	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—bone cancer	4.74e-05	0.000796	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP3A4—bone cancer	4.72e-05	0.000791	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SPARC—bone cancer	4.66e-05	0.000782	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP3A4—bone cancer	4.65e-05	0.000779	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NT5C3A—bone cancer	4.55e-05	0.000764	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NDUFA12—bone cancer	4.54e-05	0.000761	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP2—bone cancer	4.53e-05	0.00076	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NDUFA12—bone cancer	4.5e-05	0.000754	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ENO2—bone cancer	4.43e-05	0.000744	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—GNA11—bone cancer	4.27e-05	0.000715	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.23e-05	0.00071	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.18e-05	0.0007	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GSTP1—bone cancer	4.16e-05	0.000698	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—DHFR—bone cancer	4.11e-05	0.00069	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GSTP1—bone cancer	4.03e-05	0.000676	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSTP1—bone cancer	3.98e-05	0.000667	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL3—bone cancer	3.87e-05	0.000649	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GNA11—bone cancer	3.84e-05	0.000645	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ENO2—bone cancer	3.81e-05	0.000639	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NT5C3A—bone cancer	3.76e-05	0.000631	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NT5C3A—bone cancer	3.73e-05	0.000625	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—DHFR—bone cancer	3.53e-05	0.000593	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP3A4—bone cancer	3.49e-05	0.000585	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.47e-05	0.000582	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP9—bone cancer	3.41e-05	0.000571	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GNA11—bone cancer	3.3e-05	0.000554	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ENO2—bone cancer	3.2e-05	0.000537	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ENO2—bone cancer	3.11e-05	0.000521	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—bone cancer	3.02e-05	0.000507	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP3A4—bone cancer	3e-05	0.000502	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTP1—bone cancer	2.98e-05	0.0005	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.98e-05	0.0005	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—DHFR—bone cancer	2.97e-05	0.000499	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NDUFA12—bone cancer	2.97e-05	0.000498	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—DHFR—bone cancer	2.88e-05	0.000483	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GNA11—bone cancer	2.78e-05	0.000466	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EGFR—bone cancer	2.75e-05	0.000462	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GNA11—bone cancer	2.69e-05	0.000452	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTP1—bone cancer	2.56e-05	0.00043	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PLAU—bone cancer	2.54e-05	0.000425	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP3A4—bone cancer	2.52e-05	0.000422	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NT5C3A—bone cancer	2.46e-05	0.000412	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP3A4—bone cancer	2.44e-05	0.000409	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.43e-05	0.000407	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ENO2—bone cancer	2.32e-05	0.000388	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—bone cancer	2.25e-05	0.000378	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—bone cancer	2.15e-05	0.000361	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTP1—bone cancer	2.15e-05	0.000361	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—DHFR—bone cancer	2.15e-05	0.00036	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—bone cancer	2.09e-05	0.00035	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTP1—bone cancer	2.09e-05	0.00035	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—bone cancer	2.06e-05	0.000345	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GNA11—bone cancer	2.01e-05	0.000337	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ENO2—bone cancer	1.99e-05	0.000335	CbGpPWpGaD
Nateglinide—ALB—Metabolism—DHFR—bone cancer	1.85e-05	0.00031	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP3A4—bone cancer	1.82e-05	0.000305	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GNA11—bone cancer	1.73e-05	0.00029	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ENO2—bone cancer	1.65e-05	0.000276	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ENO2—bone cancer	1.63e-05	0.000274	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP3A4—bone cancer	1.57e-05	0.000263	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.56e-05	0.000262	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—bone cancer	1.56e-05	0.000261	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—bone cancer	1.54e-05	0.000259	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—DHFR—bone cancer	1.53e-05	0.000256	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—DHFR—bone cancer	1.51e-05	0.000254	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GNA11—bone cancer	1.43e-05	0.00024	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GNA11—bone cancer	1.42e-05	0.000237	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—bone cancer	1.34e-05	0.000225	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—bone cancer	1.33e-05	0.000223	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP3A4—bone cancer	1.29e-05	0.000217	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP3A4—bone cancer	1.28e-05	0.000215	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.28e-05	0.000214	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—bone cancer	1.12e-05	0.000187	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—bone cancer	1.11e-05	0.000186	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—bone cancer	1.1e-05	0.000184	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—bone cancer	1.08e-05	0.000181	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ENO2—bone cancer	1.08e-05	0.000181	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—bone cancer	1.02e-05	0.000171	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DHFR—bone cancer	9.99e-06	0.000168	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GNA11—bone cancer	9.34e-06	0.000157	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—bone cancer	8.07e-06	0.000135	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—bone cancer	7.24e-06	0.000121	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—bone cancer	6.95e-06	0.000117	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—bone cancer	5.74e-06	9.62e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—bone cancer	5.69e-06	9.54e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—bone cancer	3.75e-06	6.29e-05	CbGpPWpGaD
